Edgewood Management LLC lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 817,803 shares of the company’s stock after selling 4,100 shares during the quarter. Colgate-Palmolive comprises about 0.3% of Edgewood Management LLC’s investment portfolio, making the stock its 24th biggest position. Edgewood Management LLC’s holdings in Colgate-Palmolive were worth $59,577,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the business. Jacobi Capital Management LLC lifted its stake in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares during the period. Krilogy Financial LLC lifted its stake in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares during the period. Hanson & Doremus Investment Management lifted its stake in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after purchasing an additional 70 shares during the period. Captrust Financial Advisors purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth $122,000. Finally, AlphaMark Advisors LLC lifted its stake in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the period. Hedge funds and other institutional investors own 72.83% of the company’s stock.
Colgate-Palmolive (NYSE CL) opened at $74.62 on Friday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The firm has a market capitalization of $65,462.75, a price-to-earnings ratio of 28.81, a P/E/G ratio of 3.15 and a beta of 0.80. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
CL has been the topic of a number of recent analyst reports. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research note on Monday, October 23rd. Deutsche Bank initiated coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Stifel Nicolaus set a $73.00 target price on Colgate-Palmolive and gave the stock a “hold” rating in a research report on Sunday, October 29th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.51.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $73.07, for a total value of $730,700.00. Following the transaction, the insider now directly owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares in the company, valued at $2,557,619.36. The disclosure for this sale can be found here. Insiders sold 181,950 shares of company stock worth $13,237,385 over the last three months. 1.02% of the stock is currently owned by corporate insiders.
WARNING: “Edgewood Management LLC Has $59.58 Million Holdings in Colgate-Palmolive (CL)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.com-unik.info/2018/01/13/edgewood-management-llc-has-59-58-million-holdings-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
What are top analysts saying about Colgate-Palmolive? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive and related companies.